The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Neoadjuvant treatment of locally advanced GIST: Results of APOLLON, a prospective, open label phase II study in KIT- or PDGFRA-positive tumors.
Peter Hohenberger
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Novartis
Claus Langer
Honoraria - Novartis
Clemens Martin Wendtner
Honoraria - Novartis
Research Funding - Novartis
Werner Hohenberger
No relevant relationships to disclose
Annette Pustowka
Employment or Leadership Position - Novartis
Eva Wardelmann
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Novartis
Elisabeth Andre
No relevant relationships to disclose
Thomas Licht
Consultant or Advisory Role - Novartis
Honoraria - Novartis